Literature DB >> 14504770

[Experimental provocation of panic attacks as a human experimental model for anxiety].

A Ströhle1.   

Abstract

Diagnostic symptom provocation has a long tradition in medicine. In psychiatry, symptom provocation studies are used to study the pathophysiology and treatment of disorders. Sudden and unexpected panic attacks have a characteristic course and a typical pattern of somatic, cognitive, emotional, and behavioral symptoms. Beginning with the study of Pitts and McClure, who described the panicogenic activity of sodium lactate, the experimental induction of panic attacks with different challenges has been used to characterize the neurobiology of anxiety. Furthermore, experimentally induced panic attacks can be used to study possible new treatment approaches. The anxiolytic activity of atrial natriuretic peptide suggests that modulation of natriuretic peptide receptors with nonpeptidergic ligands may be a new treatment approach. Experimentally induced panic attacks are a tool to characterize the neurobiology of anxiety and panic and may be used to develop new treatment approaches.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504770     DOI: 10.1007/s00115-002-1385-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  45 in total

1.  Ventilatory physiology of patients with panic disorder.

Authors:  J M Gorman; M R Fyer; R Goetz; J Askanazi; M R Liebowitz; A J Fyer; J Kinney; D F Klein
Journal:  Arch Gen Psychiatry       Date:  1988-01

2.  Effect of flumazenil in lactate-sensitive patients with panic disorder.

Authors:  A Ströhle; M Kellner; A Yassouridis; F Holsboer; K Wiedemann
Journal:  Am J Psychiatry       Date:  1998-05       Impact factor: 18.112

3.  Endocrine and physiological changes during "spontaneous" panic attacks.

Authors:  O G Cameron; M A Lee; G C Curtis; D S McCann
Journal:  Psychoneuroendocrinology       Date:  1987       Impact factor: 4.905

4.  Lactate infusion in the treatment of 'free-floating' anxiety.

Authors:  J A Bonn; J Harrison; L Rees
Journal:  Can Psychiatr Assoc J       Date:  1973-02

5.  Lactate metabolism in anxiety neurosis.

Authors:  F N Pitts; J N McClure
Journal:  N Engl J Med       Date:  1967-12-21       Impact factor: 91.245

6.  Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].

Authors:  S E Breuning; D G Ferguson; S Cullari
Journal:  Psychopharmacol Bull       Date:  1981-01

7.  Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.

Authors:  K Wiedemann; H Jahn; A Yassouridis; M Kellner
Journal:  Arch Gen Psychiatry       Date:  2001-04

8.  Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients.

Authors:  J Bradwejn; D Koszycki
Journal:  Am J Psychiatry       Date:  1994-02       Impact factor: 18.112

9.  Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic.

Authors:  M Kellner; L Herzog; A Yassouridis; F Holsboer; K Wiedemann
Journal:  Am J Psychiatry       Date:  1995-09       Impact factor: 18.112

10.  Selective antagonists of benzodiazepines.

Authors:  W Hunkeler; H Möhler; L Pieri; P Polc; E P Bonetti; R Cumin; R Schaffner; W Haefely
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

View more
  1 in total

1.  DIDS (4,4-diisothiocyanatostilbenedisulphonic acid) induces apoptotic cell death in a hippocampal neuronal cell line and is not neuroprotective against ischemic stress.

Authors:  Matthew E Pamenter; Guy A Perkins; Xiang Q Gu; Mark H Ellisman; Gabriel G Haddad
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.